These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A catalog of prostate cancer nomograms. Ross PL; Scardino PT; Kattan MW J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918 [TBL] [Abstract][Full Text] [Related]
7. An updated catalog of prostate cancer predictive tools. Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041 [TBL] [Abstract][Full Text] [Related]
8. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling. Nguyen CT; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545 [TBL] [Abstract][Full Text] [Related]
9. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer. Schlomm T; Chun FKh; Erbersdobler A Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063 [TBL] [Abstract][Full Text] [Related]
10. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Nguyen CT; Zelefsky MJ; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540 [TBL] [Abstract][Full Text] [Related]
13. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Voorzanger-Rousselot N; Garnero P Cancer Treat Rev; 2007 May; 33(3):230-83. PubMed ID: 17433551 [TBL] [Abstract][Full Text] [Related]
14. Molecular and prognostic markers in prostate cancer. A study of cell-cycle regulators, angiogenesis and candidate markers. Halvorsen OJ APMIS Suppl; 2008; (123):5-62. PubMed ID: 18771090 [No Abstract] [Full Text] [Related]
15. Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers. Bjartell A; Montironi R; Berney DM; Egevad L Acta Oncol; 2011 Jun; 50 Suppl 1():76-84. PubMed ID: 21604944 [TBL] [Abstract][Full Text] [Related]
16. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Shariat SF; Karakiewicz PI; Suardi N; Kattan MW Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454 [TBL] [Abstract][Full Text] [Related]
18. The function of poliamine metabolism in prostate cancer. Palavan-Unsal N; Aloglu-Senturk SM; Arsan D Exp Oncol; 2006 Sep; 28(3):178-86. PubMed ID: 17080009 [TBL] [Abstract][Full Text] [Related]
19. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era. Bickers B; Aukim-Hastie C Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer biomarkers: a current perspective. Kumar-Sinha C; Rhodes DR; Yu J; Chinnaiyan AM Expert Rev Mol Diagn; 2003 Jul; 3(4):459-70. PubMed ID: 12877385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]